(Q43858664)

27 November 2017

title

Chronic (60-week) toxicity study of DUROS leuprolide implants in dogs (English)

1 reference

27 November 2017

1 reference

M J Cukierski

1

1 reference

27 November 2017

P A Johnson

series ordinal

2

1 reference

27 November 2017

J C Beck

series ordinal

3

1 reference

27 November 2017

publication date

1 November 2001

1 reference

International Journal of Toxicology

27 November 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

27 November 2017

volume

20

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

369-381

1 reference

Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing Hormone

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F109158101753333659

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F109158101753333659

Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F109158101753333659

Regulation of alpha and rat luteinizing hormone-beta messenger ribonucleic acids during gonadotropin-releasing hormone agonist treatment in vivo in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F109158101753333659

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F109158101753333659

10.1080/109158101753333659

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference